HEOR Staff Writer

Surge in Obesity Intervention Costs in the Netherlands
Enhancing Patient Safety in Africa’s Healthcare Transformation
FDA Confirms GLP-1 RA Safety Review: No Increased Suicidal Risk
Risicoverevening Policy Updates: Key Amendments for 2022-2025 Explained
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
NICE Endorses Dupilumab for Eosinophilic COPD Treatment